Prospector
Profile
07.1235
|
| |
| Wizzard Software Corp. |
NAICS |
511210 |
| 5001 Baum Boulevard, Suite 770
Pittsburgh, PA 15213 |
Description |
Software Publisher |
| (412) 621-0902 |
Employees |
25 |
| http://www.wizzardsoftware.com/ |
Revenue |
(mil) |
2.9430 |
| |
Income |
(mil) |
-4.7930 |
| |
Assets |
(mil) |
4.2980 |
| |
Liability |
(mil) |
0.9610 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Wizzard Software Corp. reported a net loss of $2.9 million for the second quarter ended June 30, 2007, compared with a net loss of $1.4 million for the same period ended June 30, 2006. The Company recorded revenues of $1.4 million during the second quarter ended June 30, 2007, an 83% increase from revenues of $782,046 in the second quarter of 2006 and a 97% increase over revenues in the first quarter of 2007. At June 30, 2007, the Company's consolidated balance sheet showed $20.9 million in total assets, $1.5 million in total liabilities, and $19.4 million in total stockholders' equity. The Company's assets include $18.8 million in goodwill, primarily as a result of its acquisiton of Webmayhen, Inc. and PNPP during the first half of 2007.
|
| |
|
Intellectual Property:
MedivoxRx Technologies currently has two patents pending in the United States and one patent pending in Canada for the talking prescription medication bottle. [SEC Filing 10-KSB 03-30-07]
|
| |
|
Description:
The Company provides software and hardware products and services that focus on speech recognition and text-to-speech technology.
|
| |
|
Officers:
Christopher J. Spencer (Pres., CEO & Dir.); Armen Geronian (Chief Technical Officer & Dir.); John Busshaus (CFO); Gordon Berry (Dir.); David Mansueto (Dir.); Alan Costilo (Dir.)
|
| |
|
Auditor:
Gregory & Associates LLC
|
| |
|
Securities:
Common Stock-Symbol WIZD.OB; OTC BB;
42,353,235 common shares outstanding as of August 10, 2007.
|
| |
| |
| |
| return to main page |
